PTC Therapeutics, Inc. Sale of Stock, Price Per Share
PTC Therapeutics, Inc. (PTCT) had Sale of Stock, Price Per Share of $53.37 per share as of 2020-12-31, per its 10-K filed 2023-02-21.
Discontinued › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2023-02-21
- 2020-12-31: Sale of Stock, Price Per Share $53.37.
- 2020-03-31: Sale of Stock, Price Per Share $52.81.
- 2019-09-30: Sale of Stock, Price Per Share $40.40; Sale of Stock, Price Per Share as first filed $46.60.
- 2019-01-31: Sale of Stock, Price Per Share $30.20.
| Period end | Sale of Stock, Price Per Share | Sale of Stock, Price Per Share as first filed |
|---|---|---|
| 2020-12-31 | $53.37 10-K · filed 2023-02-21 | |
| 2020-03-31 | $52.81 10-Q · filed 2020-04-30 | |
| 2019-09-30 | $40.40 10-K · filed 2022-02-22 | $46.60 10-Q · filed 2019-10-30 |
| 2019-01-31 | $30.20 10-K · filed 2022-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |